Skip to main content

Day: March 24, 2021

Winnebago Industries Announces Strong Second Quarter Fiscal 2021 Results

— Record Quarterly Revenues of $839.9 million Up 34.0% Year-Over-Year, Driven by Robust End Consumer Demand —— Organic RV Market Share Gains Continue, Rising to 11.5% (+90 Basis Points) on a Trailing Twelve Month Basis —— Second Quarter Gross Margin Expansion of 590 Basis Points to 18.6% —— Record Reported Diluted EPS of $2.04 Up 300.0%; Record Adjusted EPS of $2.12 Up 216.4% Over Prior Year —— Interest in the Outdoors Remains High as Evidenced by Elevated Order Backlogs and Retail Sales Growth — EDEN PRAIRIE, Minn., March 24, 2021 (GLOBE NEWSWIRE) — Winnebago Industries, Inc. (NYSE: WGO), a leading outdoor lifestyle product manufacturer, today reported financial results for the Company’s second quarter of Fiscal 2021. Second Quarter Fiscal 2021 ResultsRevenues for...

Continue reading

Peeter Kinnunen is appointed acting CEO of Klövern

In line with what was communicated in a press release on 29 December 2020, Rutger Arnhult will leave his position as CEO on 25 March 2021. The Board of Directors has appointed Peeter Kinnunen acting CEO of Klövern. Peeter Kinnunen is Klövern’s Head of Transactions, belongs to the Executive Management and has been employed by the company since 2012. The Board of Directors’ search process for a new CEO continues. ”Peeter Kinnunen has for many years been a very important colleague in Klövern. I am very confident that Peeter, together with the rest of the management team, will continue to run the company in the best way”, says Rutger Arnhult. Klövern AB (publ) For further information, please contact:Pia Gideon, Chairman of the Board, +46 76 768 00 76Lars Norrby, IR, +46 76 777 38 00, lars.norrby@klovern.se Klövern is a real estate company...

Continue reading

Peeter Kinnunen utses till tillförordnad VD för Klövern

I linje med vad som kommunicerades genom ett pressmeddelande den 29 december 2020 kommer Rutger Arnhult att lämna sin befattning som VD den 25 mars 2021. Som tillförordnad VD för Klövern har styrelsen utsett Peeter Kinnunen. Peeter Kinnunen är Klöverns Transaktionschef, tillhör bolagsledningen och har varit anställd i bolaget sedan 2012. Styrelsens rekryteringsprocess av en ny VD fortsätter. ”Peeter Kinnunen har varit en central och mycket viktig medarbetare i Klövern under många år. Jag är utomordentligt trygg i att Peeter, tillsammans med övriga ledningen, kommer att fortsätta driva bolaget på bästa sätt”, säger Rutger Arnhult. Klövern AB (publ) För ytterligare information, vänligen kontakta:Pia Gideon, Styrelseordförande, 076-768 00 76Lars Norrby, IR, 076-777 38 00, lars.norrby@klovern.se Klövern är ett fastighetsbolag som med närhet...

Continue reading

Final terms for bonds to be opened 26th March 2021

To Nasdaq Copenhagen A/S                                                               24th March 2021                                                                                                             Announcement no. 35/2021 Final terms for bonds to be opened 26th March 2021 On 26th March 2021, Jyske Realkredit A/S will open new covered bonds (SDO). Final terms for the bonds are attached to this announcement. The full prospectus for the Bond consist of the attached final terms and the previously disclosed ”Base Prospectus for the issue of Covered Bonds (SDO), Mortgage bonds (“RO”) and Mortgage Bonds (RO) and bonds issued pursuant to Section 15 of the Danish Mortgage-Credit Loans and Mortgage-Credit Bonds etc. Act (Section 15 Bonds).”, dated February 23th, 2021. Jyske Realkredit’s base prospectus is available on Jyske Realkredit’s...

Continue reading

Endelige vilkår for nye obligationer der åbnes den 26. marts 2021

Til Nasdaq Copenhagen A/S                                                                                       24. marts 2021                                                                                                                                                 Meddelelse nr. 35/2021 Endelige vilkår for nye obligationer der åbnes den 26. marts 2021 Jyske Realkredit åbner den 26. marts 2021 en ny særligt dækkende obligation (SDO). Med denne meddelelse følger de endelige vilkår for obligationerne. Det samlede prospekt for obligationerne består af vedlagte endelige vilkår og det tidligere offentliggjorte ”Basisprospekt for udstedelse af Særligt Dækkede Obligationer (SDO), Realkreditobligationer (RO) og obligationer i medfør af § 15 i lov om realkreditlån og realkreditobligationer m.v. (§ 15 Obligationer)”, dateret 23. februar 2021. Jyske...

Continue reading

Crinetics Pharmaceuticals to Host Webcast and Conference Call to Discuss 2021 Clinical Plans and Fourth Quarter and Full Year 2020 Financial Results

SAN DIEGO, March 24, 2021 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, today announced that it will host a webcast and conference call on Tuesday, March 30, 2021 at 4:30 p.m. ET to discuss its 2021 clinical plans and financial results for the fourth quarter and full year 2020. To access the webcast, please visit this link to the event. To participate by phone, please dial 877-407-0789 (domestic) or 201-689-8562 (international) and refer to conference ID 13717687. Following the live event, the archived webcast will be available for 90 days. About Crinetics PharmaceuticalsCrinetics Pharmaceuticals is a clinical stage pharmaceutical...

Continue reading

Emerging Markets Report: Small Wonders

An Emerging Markets Sponsored Commentary ORLANDO, Fla., March 24, 2021 (GLOBE NEWSWIRE) — Today’s featured Company is a little different than some of our more recent profiles. Frankly, we’ve seen nothing like it before. Allow us to introduce KWESST Micro Systems Inc. (TSXV: KWE) (OTCQB: KWEMF), which describes itself as “a proud leader in advancing the modern networked capability of soldiers and responders, including the networked Soldier Systems mission of NATO and its allies, with niche applications that make a critical difference to safety and effectiveness.” What really stands out about the Company’s tech is that it is all about making the science of warfare smaller and thus more efficient. This video is a must see. Everything is centered around KWESST’s proprietary “MISST” system, which is short for “Micro...

Continue reading

Nubeva Closes Software Licensing Agreement with Megazone Cloud

San Jose, California, March 24, 2021 (GLOBE NEWSWIRE) — SAN JOSE, Calif., March 23, 2021 – Nubeva Technologies Ltd. (TSX-V: NBVA), a developer of decryption software that broadens network traffic security and visibility, today announced a software license agreement with Megazone Cloud, a leading cloud-managed service provider (MSP) based in Asia. This agreement will enable Megazone to expand their Network Security product suite to answer the TLS visibility challenge in modern cloud and on-prem networks with simplified, high performance, lower cost decryption. “We are thrilled to be working with a market leader and visionary like Megazone Cloud,” said Steve Perkins, Nubeva’s Chief Marketing Officer. “The application of our TLS visibility product, to their already leading cloud services suite, will bring back visibility and control...

Continue reading

Transplantation Market to Hit USD 14.67 Billion and Grow at 10.6% CAGR by 2028; Rising Prevalence of Chronic Diseases to Fuel Demand for Organ Transplantation: states Fortune Business Insights™

Pune, India, March 24, 2021 (GLOBE NEWSWIRE) — The global transplantation market size is expected to reach USD 14.67 billion by 2028, exhibiting a CAGR of 10.6% during the forecast period. The rising prevalence of chronic diseases coupled with technological advancements will spur business opportunities for this market, states Fortune Business Insights, in a report, titled “Transplantation Market, 2021-2028.” The market size stood at USD 5.47 billion in 2020. Key Development:  September 2019: CareDx announced a strategic partnership with NanoString to expand its product portfolio. Through this partnership, the company will enhance the development of molecular assays in transplantation and improve transplant diagnostics. Request a Sample Copy of the Global Research Report:https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/transplantation-market-105049 COVID-19...

Continue reading

Myovant Sciences and Pfizer Announce Positive Data from Phase 3 LIBERTY Randomized Withdrawal Study of Once-Daily Relugolix Combination Therapy in Women with Uterine Fibroids

78.4% of women who continued on relugolix combination therapy remained responders (menstrual blood loss < 80 mL) through Week 76 compared with 15.1% of women who discontinued treatment at Week 52 (p < 0.0001) 69.8% of women who continued relugolix combination therapy remained responders through Week 104 88.3% of women who discontinued treatment relapsed with heavy menstrual bleeding, on average 5.9 weeks after discontinuation Myovant to host conference call and webcast today at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific TimeBASEL, Switzerland and NEW YORK, March 24, 2021 (GLOBE NEWSWIRE) — Myovant Sciences (NYSE: MYOV) and Pfizer Inc. (NYSE: PFE) today announced positive data from the Phase 3 LIBERTY randomized withdrawal study of relugolix combination therapy (relugolix 40 mg plus estradiol 1.0 mg and norethindrone acetate 0.5...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.